[1]
Zhu, H.J. et al. 2018. Proton therapy in stage II–IV non-small cell lung cancer: pattern of care and impact on trial accrual. Acta Oncologica. 57, 5 (May 2018), 692–693. DOI:https://doi.org/10.1080/0284186X.2017.1398413.